Загрузка...

Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expression

Androgen ablation therapy represents the first line of therapeutic intervention in men with advanced or recurrent prostate tumors. However, the incomplete efficacy and lack of durable response to this clinical strategy highlights an urgent need for alternative treatment options to improve patient ou...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: HE, SUQIN, ZHANG, CHAOHUA, SHAFI, AYESHA A., SEQUEIRA, MANUEL, ACQUAVIVA, JAIME, FRIEDLAND, JULIE C., SANG, JIM, SMITH, DONALD L., WEIGEL, NANCY L., WADA, YUMIKO, PROIA, DAVID A.
Формат: Artigo
Язык:Inglês
Опубликовано: D.A. Spandidos 2012
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3583620/
https://ncbi.nlm.nih.gov/pubmed/23152004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2012.1698
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!